Skip to content

R (1972): Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris

10: Dubiel W, Happle R. Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris. Z Haut Geschlechtskr. 1972 Jul 1;47(13):545-50. Fumaric Acid Monotherapy in the Treatment of Severe Chronic Plaque Psoriasis vulgaris. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients. Fumaric acid therapy for psoriasis: a randomized, double-blind, placebo-controlled study.

R (1972): Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris 2FAE were introduced as a systemic psoriasis treatment in 1959 and empirically developed further between 1970 and 1990 in Germany, Switzerland, and the Netherlands. 1972;47(13):545550. Werdenberg D, Joshi R, Wolffram S, Merkle HP, Langguth P. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Efficacy and safety profile of fumaric acid esters in oral long-term therapy with severe treatment refractory psoriasis vulgaris. Experimental treatment with fumaric acid monoethylester in psoriasis vul-garis. Z Haut Geschlechtskr 1972;47(13):545-50. 1972Jul. Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris. Z Haut Geschlechtskr. Z Haut Geschlechtskr 1972 Jul;47(13):545-50.

Dimethyl fumarate (DMF) is a fumaric acid ester that has been used for many years in the treatment of psoriasis and as a preservative, stored in desiccant sachets for the transport of furniture and shoes. Trevisan G. Fumaric acid and its derivatives in the treatment of psoriasis vulgaris: our experience in forty-one patients. Dubiel W, Happle R. Experimental treatment with fumaric acid monoethylester in psoriasis vulgaris. Z Haut Geschlechtskr. 1972;47(13):545-550. This invention relates to treatment or alleviation of a disease, condition or disorder selected from inflammatory bowel disease, Chron’s disease, colitis ulcerosa, Coeliac disease, dermatitis herpetiformis, dermatomyositis, enteritis allergia, erytherma nodosum leprosum, ileitis regionalis, psoriasis, purpura, scleritis or scleroderma by administering to a living body certain imidazole, triazole, or 1,4-dihydropyridine derivatives. Brugnara et al., The Journal of Pharmacology and Experimental Therapeutics, vol. Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro. No cytotoxic effect of the drug was noted during the experiments. There was no correlation between MMF dose and MPA trough concentrations (r -0.0657). MPA levels in patients treated with MMF and CsA were significantly lower than those obtained in double therapy.

Fumaric Acid Esters In The Management Of Psoriasis

Review Allergen Of The Year 2000-2015